Nemeth v. Brenntag and Toxic Tort Causation in New York: How the Court of Appeals Raised the Bar and What Mesothelioma Plaintiffs Must Now Prove
Updated: 4 days ago
Updated October 21, 2026
For decades, New Yorkers breathed in dangers they couldn't see. Maybe you handled pipe insulation at the Brooklyn Navy Yard, sanded joint compound while renovating pre-war apartments on the Upper West Side, or dusted on talcum powder every morning without a second thought. Then, 30 or 40 years later, a doctor says the word no one wants to hear: mesothelioma. In 2022, the New York Court of Appeals raised the bar for proving these cases. Its decision in Nemeth v. Brenntag rewrote the practical rules of toxic tort causation, and if your legal team doesn't understand what the court now demands, even a $16.5 million verdict can vanish on appeal.
This post explains what happened in Nemeth, what the ruling requires, and how mesothelioma, benzene leukemia, and other toxic exposure plaintiffs in Manhattan build the kind of causation proof courts now require.
Key takeaways
New York courts now require toxic exposure experts to give a scientific expression of how much of a substance you actually breathed.
Calling an exposure "significant," "frequent," or "excessive" is not enough to prove it caused your illness.
An exact measurement is not always required; simulation studies, dose models, or comparisons to published studies can supply the needed proof.
Be ready to describe how often you used the product, how close you were, and how long each session lasted.
Toxic exposure claims generally must be filed within three years of when you discovered, or should have discovered, the injury, whichever is earlier, so start early.
What Did the Court of Appeals Decide in Nemeth v. Brenntag?
In April 2022, New York's highest court threw out a $16.5 million Manhattan asbestos-talc verdict because the plaintiff's experts never showed, in scientific terms, how much asbestos she actually inhaled. The decision is Nemeth v. Brenntag North America, 38 N.Y.3d 336 (2022), and it's now the single most important causation case in New York toxic exposure litigation.
The facts were sympathetic. Florence Nemeth used Desert Flower talcum powder daily from 1960 to 1971. Decades later, she was diagnosed with peritoneal mesothelioma — a cancer of the lining of the abdomen that, as the National Cancer Institute explains, is overwhelmingly linked to asbestos and often appears only decades after exposure. A jury in New York County Supreme Court found the talc supplier liable and awarded her family $16.5 million.
At trial, her team relied on two key experts. A geologist ran what's called a "glove box" test: he agitated a vintage sample of the powder inside a sealed chamber and counted the asbestos fibers it released into the air. A physician then testified that Mrs. Nemeth's exposure was at levels "significant" enough to cause mesothelioma.
The Court of Appeals said that wasn't enough. Fibers released in a sealed laboratory chamber don't tell a jury what a real person breathed while applying powder in her own bathroom. And calling an exposure "significant" is a conclusion, not a scientific measurement. Without some scientific expression of the dose Mrs. Nemeth actually inhaled, and proof connecting that dose to levels known to cause mesothelioma, the causation case failed as a matter of law. The court reversed the verdict and dismissed the case outright, over a forceful dissent warning that the majority was setting an almost impossible burden for victims of diseases with long latency periods.
That's the stakes in one sentence: a family litigated for years, won at trial, and walked away with nothing because the expert proof on toxic tort causation didn't satisfy the court's standard.
What Is the Parker Standard for Toxic Tort Causation in New York?
The Parker standard is New York's three-part test for proving that a toxic substance caused a plaintiff's illness, and Nemeth is best understood as a strict application of it. The test comes from Parker v. Mobil Oil Corp., 7 N.Y.3d 434 (2006), a case brought by a gas station attendant who developed leukemia after years of exposure to benzene in gasoline.
Under Parker, a plaintiff's experts must establish three things:
The plaintiff was actually exposed to the specific toxin, such as asbestos or benzene.
General causation — meaning the toxin is capable of causing the plaintiff's particular disease at all.
Specific causation — meaning the plaintiff was exposed to enough of the toxin to have caused his or her disease.
General causation is rarely the battleground in asbestos cases. OSHA flatly warns that there is no safe level of asbestos exposure, and CDC researchers have documented a substantial number of malignant mesothelioma deaths in the United States. The fight is almost always over specific causation: proving that your exposure was heavy enough, long enough, or concentrated enough to have caused your cancer.
Here's the part defense lawyers don't emphasize: Parker itself is flexible. The Court of Appeals said plaintiffs don't always need a precise numerical measurement of their exposure. Experts can use mathematical modeling, estimates based on how the plaintiff worked, or comparisons to published studies of workers with similar exposures. The court reaffirmed that flexibility in later cases, including Sean R. v. BMW of North America, while rejecting shortcuts like estimating dose from the strength of an odor.
Nemeth didn't overrule any of that. What it did was close the loophole of vague adjectives. "Significant," "regular," "frequent," and "excessive" are no longer acceptable substitutes for a scientific expression of dose. The court has been active across injury law in recent years (we've covered its rulings on premises liability at golf courses and the assumption of risk doctrine in sports cases), but Nemeth stands out because it took away a completed verdict.
How Do Mesothelioma and Benzene Plaintiffs Prove Specific Causation After Nemeth?
After Nemeth, plaintiffs prove specific causation by turning their exposure history into numbers, or into a rigorous scientific comparison, before trial ever starts. The disease itself hasn't changed. Mesothelioma still develops silently over decades, and NIOSH still recognizes asbestos as the driving cause. What changed is the packaging of the proof.
The strongest tool is the exposure simulation study. A certified industrial hygienist recreates the plaintiff's actual activity (mixing joint compound, blowing out brake drums, applying talc) and measures the asbestos fiber concentration in the breathing zone with air sampling equipment. That's exactly what the glove box test in Nemeth failed to do. A chamber test measures what a product can release; a simulation measures what a person in the plaintiff's position would inhale. The difference decided a $16.5 million case.
From there, experts build a cumulative dose estimate. Frequency, duration, and proximity get converted into a lifetime exposure figure, often expressed in fiber-per-cubic-centimeter years for asbestos or parts-per-million years for benzene. The final step is the comparison: the expert lines up the plaintiff's estimated dose against published epidemiological studies showing disease occurring at similar or lower levels. When the plaintiff's dose sits comfortably inside the range that the medical literature links to mesothelioma or leukemia, the Parker/Nemeth standard is satisfied.
The inputs matter as much as the math. In Lotrean v. 3M Co., 2025 NY Slip Op 06136 (App. Div. 1st Dep't 2025), the First Department dismissed a benzene-related blood cancer claim on summary judgment. The plaintiffs' experts had assumed, without evidence, that the defendants' solvents were contaminated with benzene. That unsupported assumption left their exposure calculations with no evidentiary value, and the claim failed on both general and specific causation.
None of this works without detailed testimony. The plaintiff, coworkers, and family members must describe how often the product was used, how close the person was, how long each session lasted, and whether visible dust hung in the air. Those everyday details are the raw inputs for the dose model, which is why a firm spends hours preparing exposure testimony rather than settling for "I used it a lot."
A 2024 First Department decision shows how this preparation plays out in court. In Matter of New York City Asbestos Litig., 2024 NY Slip Op 00977 (App. Div. 1st Dep't 2024), the court upheld a mesothelioma verdict because the plaintiff's industrial hygienist, epidemiologist, and surgeon together supplied a scientific expression of exposure that satisfied Nemeth. The industrial hygienist based his quantitative estimates of the plaintiff's cumulative asbestos exposure on the details of the plaintiff's own testimony.
Timing matters too. Under CPLR § 214-c, a claim for injury caused by the latent effects of exposure to a harmful substance generally must be filed within three years of when you discovered the injury or reasonably should have discovered it, whichever is earlier. A mesothelioma diagnosis starts that clock, so the scientific workup has to begin almost immediately.
The biggest mistake we see in injury cases of every kind is waiting to get medical treatment. The longer the gap between the accident and your first visit, the harder it is to prove the accident caused your injuries, and the less believable the claim becomes to an insurer or a jury.
How Does Nemeth Change Litigation Strategy in Manhattan's Asbestos Court?
In practical terms, Nemeth moved the decisive battle in New York City Asbestos Litigation (NYCAL) from the courtroom to the expert file. NYCAL is the dedicated part of New York County Supreme Court at 60 Centre Street in Manhattan that handles asbestos cases, and since 2022 defense firms there have made Nemeth motions a standard weapon — moving before trial to preclude plaintiff experts or win summary judgment on the ground that the causation proof is merely qualitative. Manhattan's Appellate Division, First Department, which reviews NYCAL verdicts, has applied Nemeth to unwind other large talc awards, so the threat isn't theoretical.
NYCAL's accelerated docket for gravely ill plaintiffs cuts both ways: it can push a dying plaintiff's case to trial in a matter of months, but that same speed compresses the window to commission the simulation studies and dose reconstruction that Nemeth demands, so the science has to start the day the case is signed up.
The second strategic shift is verdict protection. A trial verdict is no longer the finish line; the record has to survive two layers of appellate review. That means getting the quantified dose testimony, the air sampling data, and the published comparison studies into evidence in admissible form — clearly, on the record, with the expert walking the jury through the math. An appellate court can't affirm proof it can't find in the transcript. Other cases show, as in our breakdown of Galette v. NJ Transit, how a single appellate decision reshapes strategy for every case that follows. Nemeth is that decision for toxic exposure claims.
The same logic reaches beyond asbestos. Benzene leukemia cases, solvent exposure claims, and even landlord toxic exposure cases (like the carbon monoxide poisoning verdicts we've covered) all live under the Parker framework. And because these are catastrophic, often terminal injuries, the stakes are high; our review of what NYC personal injury cases are worth in 2025 and 2026 shows why defendants fight causation so hard. With stakes like these, a causation challenge is often the defense's preferred way out.
What Questions Do Toxic Exposure Victims Ask After Nemeth?
The most common questions we hear all come back to the same fear: does the tougher toxic tort causation standard mean my case is over before it starts? Not necessarily. It means the case has to be built correctly from day one. Here are the answers families ask for most.
Do I need an exact measurement of my asbestos exposure to prove my case?
No. Parker and Nemeth both say precise quantification isn't always required. What you need is some scientific expression of your exposure (a simulation study, a mathematical dose model, or a rigorous comparison to published studies of similarly exposed workers) rather than an expert simply calling the exposure "significant."
How long do I have to file a mesothelioma lawsuit in New York?
Generally, three years from the date you discovered the injury or reasonably should have discovered it, whichever is earlier, under CPLR § 214-c. Because the scientific workup takes months, you shouldn't wait — the diagnosis effectively starts both the legal clock and the evidence-building clock.
Does Nemeth apply only to asbestos and talc cases?
No. It applies to every toxic exposure case in New York — benzene, solvents, lead, contaminated water, and more. Any claim that a substance caused a disease must satisfy the same three-part causation test, with a scientific expression of dose.
Can a jury verdict really be taken away on appeal?
Yes. That's exactly what happened in Nemeth: a $16.5 million Manhattan verdict was reversed and the case dismissed because the appellate record lacked quantified causation proof. Protecting a verdict means building appeal-proof science before trial, not after.
The Bottom Line
Nemeth v. Brenntag raised the bar for toxic tort causation in New York, but it didn't close the courthouse doors. Mesothelioma and toxic exposure victims can still bring these claims, and courts now look for proof built early: simulation studies, dose reconstruction, and experts who can put real numbers behind the diagnosis. To see how Reza Yassi pursues claims against the companies behind talc and asbestos products, visit our product liability practice page.
If you or someone you know has been diagnosed with mesothelioma or another illness caused by toxic exposure in New York, Reza Yassi at Yassi Law P.C. is ready to help. Call us today at 646-992-2138 for a consultation.
Prior results do not guarantee a similar outcome.
This article is for informational purposes only and does not constitute legal advice. Although I am an attorney, I am not your attorney, and reading this article does not create an attorney-client relationship. Laws vary by jurisdiction and may have changed since the publication of this article. For advice specific to your situation, consult a qualified attorney.
.png)